Rosetta Genomics Ltd. was a molecular diagnostics company with offices in Israel and the United States that uses micro-ribonucleic acid biomarkers to develop diagnostic tests designed to differentiate between various types of cancer. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Rosetta Genomics (Israel), Israel, covering academic research published from 2004 to 2020. Read More.
Open Access Percentage
52%
Total
Publications
94
Total Open
Publications
49
Total
Citations
12K
Open Access
Percentage
52%
Total
Publications
94
Total Open
Publications
49
Total
Citations
12K
Breakdown
Publisher Open
17%
Both
29%
Other Platform Open
6%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
13
Hybrid 35%
15
No Guarantees 35%
15
Other Platform Open
Domain 88%
29
Public 24%
8
Institution 9%
3
Other Internet 3%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
Europe PMC | Domain | 29 |
PubMed Central | Domain | 28 |
Semantic Scholar | Public | 5 |
Figshare | Public | 3 |
University of Cambridge - Apollo | Institution | 2 |
University of Oxford - Oxford Academic Notes & Queries | Institution | 1 |
Politecnico di Torino - PORTO Publications Open Repository TOrino | Institution | 1 |
CiteSeer X | Other Internet | 1 |